Search results
Order by most recent / most popular / relevance
Results: 1-10 of 24
India Supreme Court requests removal of industry reps from safety enforcement panels
- Shook Hardy & Bacon LLP
- -
- India
- -
- February 11 2011
Ruling on a request by a non-governmental organization (NGO), two supreme court justices in India have reportedly asked the government to remove food and soft drink company representatives from food-safety standards and enforcement panels
Large pharmaceutical companies look to buy niche Indian biotech firms
- Shook Hardy & Bacon LLP
- -
- India, USA
- -
- January 13 2011
Major pharmaceutical companies are reportedly buying niche biotech firms in India to take advantage of emerging opportunities involving biosimilar drugs, which are expected to have a market share of approximately $78 billion by 2013
India ponders domestic impact of biopharma takeovers
- Shook Hardy & Bacon LLP
- -
- India
- -
- March 10 2011
According to a news source, recent takeovers of India's key drug companies by foreign pharmaceutical interests have policymakers worried about the potential impact on domestic drug markets and prices
House Subcommittee addresses policies blocking U.S. exports to India
- Shook Hardy & Bacon LLP
- -
- India, USA
- -
- March 21 2013
The House Ways and Means Trade Subcommittee recently held a hearing on U.S.-India trade relations during which industry groups reportedly called on
Drug launch within six months of controller general approval now required in India
- Shook Hardy & Bacon LLP
- -
- India
- -
- January 24 2013
According to a news source, the Drugs Controller General of India (CG) has announced that pharmaceutical companies failing to launch their drugs
Indian official calls for passage of biotech regulatory legislation and increased VC funding
- Shook Hardy & Bacon LLP
- -
- India
- -
- February 16 2012
A biotechnology industry spokesperson has reportedly pointed to the lack of a proper regulatory framework in India as one of several hurdles the industry will have to surmount to grow
India issues draft guidelines on clinical trial and data submission requirements for new drug approval
- Shook Hardy & Bacon LLP
- -
- India
- -
- August 18 2011
The Central Drugs Standard Control Organization (CDSCO) of India’s Ministry of Health and Family Welfare has issued draft guidelines on the clinical trial and data submission requirements that drug makers must meet before new drugs can be manufactured, marketed or imported into India
India biotech sector set to reach $10 billion by 2015
- Shook Hardy & Bacon LLP
- -
- India
- -
- May 19 2011
According to a news source, India's biotechnology sector is expected to reach $10 billion in revenue by 2015
Indian officials to scrutinize pharmaceutical M&As
- Shook Hardy & Bacon LLP
- -
- India
- -
- October 20 2011
Indian ministry officials have apparently decided that foreign companies may continue to invest in new pharmaceutical industry projects but that foreign proposals for mergers and acquisitions in this sector will have to undergo enhanced scrutiny
India’s biotechnology regulatory bill faces opposition
- Shook Hardy & Bacon LLP
- -
- India
- -
- November 17 2011
According to a news source, the proposed Biotechnology Regulatory Authority of India Bill, 2011, was withdrawn from the Monsoon Session of Parliament after congressional members and others objected to placing the new regulatory agency under the authority of the Ministry of Science & Technology
Current Search
- Firm Name - Shook Hardy & Bacon LLP
- Jurisdiction - India
Suggested Facets
Author
- Chris A. Johnson (17)
- John D. Garretson (14)
- Madeleine McDonough (24)
- Mark Anstoetter (4)
- Patrick Henderson (20)
- Thomas T. Moga (20)